You are using an older browser version. Please use a supported version for the best MSN experience.

AstraZeneca says on track to deliver on COVID shots as sales hit $275 million

AstraZeneca said its COVID-19 vaccine contributed $275 million to first-quarter sales but shaved three cents per share from its earnings, as it posted better-than-expected results and forecast growth in the second half. Ciara Lee reports
image beaconimage beaconimage beacon